Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Colombo

Showing results (131-140 of 156) with videos related to

Pageof 16
Sort By:
Cancer Research|December 1, 1994
Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvantsA Allione, M Consalvo, P Nanni, et al.
International Journal of Cancer|August 19, 1993
Human melanoma cells express a functional interleukin-2 receptorS Plaisance, E Rubinstein, A Alileche, et al.
Molecular Carcinogenesis|January 1, 1992
Multiple molecular alterations in mouse lung tumorsF C Re, G Manenti, M G Borrello, et al.
Human Gene Therapy|September 1, 1994
Interleukin-2 gene-transduced human melanoma cells efficiently stimulate MHC-unrestricted and MHC-restricted autologous lymphocytesF Arienti, J Sulé-Suso, C Melani, et al.
Human Gene Therapy|August 1, 1994
Active immunization of metastatic melanoma patients with interleukin-4 transduced, allogeneic melanoma cells. A phase I-II studyN Cascinelli, R Foà, G Parmiani, et al.
Advances in Experimental Medicine and Biology|February 23, 1999
IL-4 gene transfer for the treatment of experimental gliomasS Benedetti, F Di Meco, N Cirenei, et al.
Cell Death & Disease|November 16, 2013
Smac mimetics induce inflammation and necrotic tumour cell death by modulating macrophage activityD Lecis, M De Cesare, P Perego, et al.
Human Pathology|December 1, 1992
Evaluation of osteonectin as a diagnostic marker of osteogenic bone tumorsM Serra, M C Morini, K Scotlandi, et al.
Journal of Cellular Physiology|October 31, 2000
Overexpression of protectin (CD59) down-modulates the susceptibility of human melanoma cells to homologous complementS Coral, E Fonsatti, L Sigalotti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1998
Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killingL Rivoltini, M Radrizzani, P Accornero, et al.
Pageof 16

Showing results (131-140 of 156) with videos related to

Sort By:
Pageof 16
Cancer Research|December 1, 1994
Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvantsA Allione, M Consalvo, P Nanni, et al.
International Journal of Cancer|August 19, 1993
Human melanoma cells express a functional interleukin-2 receptorS Plaisance, E Rubinstein, A Alileche, et al.
Molecular Carcinogenesis|January 1, 1992
Multiple molecular alterations in mouse lung tumorsF C Re, G Manenti, M G Borrello, et al.
Human Gene Therapy|September 1, 1994
Interleukin-2 gene-transduced human melanoma cells efficiently stimulate MHC-unrestricted and MHC-restricted autologous lymphocytesF Arienti, J Sulé-Suso, C Melani, et al.
Human Gene Therapy|August 1, 1994
Active immunization of metastatic melanoma patients with interleukin-4 transduced, allogeneic melanoma cells. A phase I-II studyN Cascinelli, R Foà, G Parmiani, et al.
Advances in Experimental Medicine and Biology|February 23, 1999
IL-4 gene transfer for the treatment of experimental gliomasS Benedetti, F Di Meco, N Cirenei, et al.
Cell Death & Disease|November 16, 2013
Smac mimetics induce inflammation and necrotic tumour cell death by modulating macrophage activityD Lecis, M De Cesare, P Perego, et al.
Human Pathology|December 1, 1992
Evaluation of osteonectin as a diagnostic marker of osteogenic bone tumorsM Serra, M C Morini, K Scotlandi, et al.
Journal of Cellular Physiology|October 31, 2000
Overexpression of protectin (CD59) down-modulates the susceptibility of human melanoma cells to homologous complementS Coral, E Fonsatti, L Sigalotti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1998
Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killingL Rivoltini, M Radrizzani, P Accornero, et al.
Pageof 16